mesalamine has been researched along with Prostatic Neoplasms in 7 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effectiveness of metronidazole in combination with corticosteroids in enema and mesalazine (5-aminosalicylic acid) in comparison with the same protocol without metronidazole in the treatment of chronic radiation proctitis." | 9.09 | Metronidazole in the treatment of chronic radiation proctitis: clinical trial. ( Cavcić, J; Jelincić, Z; Martinac, P; Panijan-Pezerović, R; Turcić, J; Unusić, J; Zupancić, B, 2000) |
| "To evaluate the effectiveness of metronidazole in combination with corticosteroids in enema and mesalazine (5-aminosalicylic acid) in comparison with the same protocol without metronidazole in the treatment of chronic radiation proctitis." | 5.09 | Metronidazole in the treatment of chronic radiation proctitis: clinical trial. ( Cavcić, J; Jelincić, Z; Martinac, P; Panijan-Pezerović, R; Turcić, J; Unusić, J; Zupancić, B, 2000) |
| "Balsalazide is a new-generation 5-ASA drug that yields a high concentration of active drug to the distal colon." | 2.71 | Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients. ( Bettenhausen, D; Jahraus, CD; Malik, U; Sellitti, M; St Clair, WH, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sanguineti, G | 1 |
| Franzone, P | 1 |
| Marcenaro, M | 1 |
| Foppiano, F | 1 |
| Vitale, V | 1 |
| Jahraus, CD | 2 |
| Rubin, DT | 1 |
| Scherl, EJ | 1 |
| Bettenhausen, D | 2 |
| Malik, U | 1 |
| Sellitti, M | 1 |
| St Clair, WH | 1 |
| Teshima, T | 1 |
| Hanks, GE | 1 |
| Hanlon, AL | 1 |
| Peter, RS | 1 |
| Schultheiss, TE | 1 |
| Cavcić, J | 1 |
| Turcić, J | 1 |
| Martinac, P | 1 |
| Jelincić, Z | 1 |
| Zupancić, B | 1 |
| Panijan-Pezerović, R | 1 |
| Unusić, J | 1 |
| Venkatesh, KS | 1 |
| Ramanujam, P | 1 |
| Freund, U | 1 |
| Schölmerich, J | 1 |
| Siems, H | 1 |
| Kluge, F | 1 |
| Schäfer, HE | 1 |
| Wannenmacher, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Postoperative or Salvage Radiotherapy for Node Negative Prostate Cancer Following Radical Prostatectomy[NCT00969111] | 70 participants (Anticipated) | Interventional | 2009-08-31 | Recruiting | |||
| An Expanded Phase II Study of Hypofractionated Dose Intense Image Guided Proton Radiation Therapy for Low and Intermediate Risk Adenocarcinoma of the Prostate[NCT01368055] | 361 participants (Actual) | Interventional | 2011-09-30 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for mesalamine and Prostatic Neoplasms
| Article | Year |
|---|---|
Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma. A randomized study.
Topics: Acute Disease; Aged; Aged, 80 and over; Contraindications; Data Interpretation, Statistical; Dose Fr | 2003 |
Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients.
Topics: Acute Disease; Aged; Aminosalicylic Acids; Anti-Ulcer Agents; Colon, Sigmoid; Double-Blind Method; H | 2005 |
Metronidazole in the treatment of chronic radiation proctitis: clinical trial.
Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Beta | 2000 |
Metronidazole in the treatment of chronic radiation proctitis: clinical trial.
Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Beta | 2000 |
Metronidazole in the treatment of chronic radiation proctitis: clinical trial.
Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Beta | 2000 |
Metronidazole in the treatment of chronic radiation proctitis: clinical trial.
Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Beta | 2000 |
[Unwanted side-effects in using mesalazine (5-aminosalicylic acid) during radiotherapy].
Topics: Aged; Aged, 80 and over; Aminosalicylic Acids; Clinical Trials as Topic; Double-Blind Method; Humans | 1987 |
3 other studies available for mesalamine and Prostatic Neoplasms
| Article | Year |
|---|---|
Inflammation's role in rectal cancer following prostate radiotherapy, and emerging evidence for a protective role for balsalazide.
Topics: Aminosalicylic Acids; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; | 2005 |
Rectal bleeding after conformal 3D treatment of prostate cancer: time to occurrence, response to treatment and duration of morbidity.
Topics: Aged; Aged, 80 and over; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Gastrointest | 1997 |
Endoscopic therapy for radiation proctitis-induced hemorrhage in patients with prostatic carcinoma using argon plasma coagulator application.
Topics: Administration, Oral; Administration, Rectal; Administration, Topical; Aged; Aged, 80 and over; Anti | 2002 |